Elmazoglu, et al. (72) |
OA |
Human OA chondrocyte |
BMP |
S-allylcysteine exhibits anti-osteoarthritic properties through suppressing the expression of IL-1β, IL-6, OPN and BMP in chondrocytes. |
Qian, et al. (71) |
OA |
Serum and synovial tissue |
BMD |
Increased serum OPN level in OA and RA is related to the activity of osteoclasts and bone erosion in CIA mice. |
Lin, et al. (45) |
OA |
Subchondral bone and osteoclasts |
OCN, Runx2, ALP |
OPN promotes osteoclastogenesis in the subchondral bone, regulates OA subchondral bone metabolism and accelerates subchondral bone remodeling. |
Cassuto, et al. (53) |
OA |
OA patients blood samples |
BALP, OPG, sclerostin |
Total hip arthroplasties patients present the second peak of inflammation five years post-surgery which may stimulate bone remodeling and new synthetic coupling, characterized by increasing bone anabolic transition markers BALP and RANKL/OPG. |
Kulsirirat, et al. (73) |
OA |
Mesenchymal stem cells |
Runx2, Sox9, OPN |
Andrographolide enhance osteogenesis and chondrogenesis by increasing the expression of osteogenic and chondrogenic differentiation, including Runx2, OPN, Sox9. |
Li, et al. (51) |
OA |
Adipose mesenchymal stem cell |
OCN, Runx2 |
IL-1β treatment inhibits the viability and migration of chondrocytes, enhances cell apoptosis, increase OPN level, decrease the mRNA and protein level of Col1a1, Col2a1, OCN, Runx2. Extracellular vesicles-chitosan oligosaccharide conjugates could reverse the effect of IL-1β on cartilage damage. |
Tang, et al. (74) |
OP |
C57/B6L mice and chondrocytes |
Sox9, CyclinD1, PTH1R, Osx, Runx2, ATF4, OCN, OPN |
Runx1f/fCol2α1-cre mice exhibits impaired cartilage formation, decreases bone density, accompanied with decreased expression of osteoblast differentiation genes including Osx, Runx2, ATF4 and osteoblast marker genes including OCN and OPN in chondrocytes. |
Xiao, et al. (75) |
OP |
C57BL/6 J mice |
Vascular endothelial growth factor (VEGF) |
Ovariectomy mice presents osteoporosis of the vertebra and osteochondral remodeling of the endplate with increased endplate porosity and decreased disc volume. |
Li, et al. (76) |
OP |
Human osteoblast-like cells and mice |
Collagen I, OCN, OPN |
Aucubin increase cortical bone thickness, bone density and tighter trabecular bone in Dex-induced osteoporotic mouse model, up-regulates the expression of collagen I, OCN, OPN in cells. |
Gu, et al. (77) |
OP |
Wistar rats |
BMD, BMP2, Runx2, Collagen I, ALP |
Anti-Osteoporosis Decoction (AOD) and Yougui Pill treatment effectively inhibits osteoporosis and reduces the broken trabecular bones, increases the level of BMD, ALP levels, accompanied by the increased expressions of BMP2, Runx2, Collagen I and OPN. |
Zeng, et al. (78) |
OP |
Human bone marrow mesenchymal stem cells |
Runx2, OCN, and OPN |
Artesunate promotes osteoblasts differentiation related proteins Runx2, OCN and OPN expression through activating the Wnt signaling pathway in hBMSCs. |
Dong, et al. (79) |
OP |
Mouse preosteoblast cell lines (MC3T3-E1) |
ALP, OCN, OPN, and BMP2 |
Anagliptin significantly increased matrix deposition and mineralization by osteoblasts, as evidenced by elevated levels of ALP, OCN, OPN, and BMP2. |
Lei, et al. (60) |
OP |
C57B/L6 mice and osteoclasts |
Runx2, OPN, TRAP |
MLN64 was over-expressed during the process of osteoclast differentiation, up-regulation Runx2 and OPN. The in vivo study suggested that MLN64 deletion reversed streptozotocin-induced trabecular deleterious effects and stimulated bone remodeling. |
Yin, et al. (80) |
OP |
Zebrafish |
ALP, hydroxyproline, and TRAP |
Evodiamine (EV) can alleviate dexamethasone-induced osteoporosis through increasing the area of bone formation, the content of hydroxyproline and the expression of ALP and TRAP in zebrafish. |
Fan, et al. (81) |
OP |
Sprague-Dawley rats |
BMD, ALP, OCN, BMP2, Runx2, TRAP |
Myricetin could increase body weight gain and inhibit Dex-induced reduction in BMD, enhanced ALP activity, upregulated OCN, BMP2 and Runx2 levels accompanied with reduced TRAP activity and CTX level. |
Wu, et al. (82) |
OP |
Human plasma samples |
B lymphocyte chemoattractant (BLC) and BMP |
Inflammatory cytokines were closely related with OP, BLC, OPN and IGFBP4 are greatly related to the pathogenesis of OP. |
Lee, et al. (83) |
OP |
Female ICR mice |
collagen type I, BMP2 and OPN |
Osteo-F ameliorated bone loss by increasing bone forming molecules including BMP-2 and OPN in osteoporosis. |
Marycz, et al. (84) |
OP |
MC3T3-E1cell lines |
OPN, OCN and ALP |
PRHD@MnFe2O4 protect osteoporosis through enhancing the expression of bone remodeling markers including OPN, osteocalcin (OCL) and ALP in pre-osteoblasts. |
Shao, et al. (85) |
OP |
MC3T3-E1 cells |
ALP, osteocalcin, OPN and BMP-2 |
Trelagliptin increased the activity of ALP and promoted osteoblastic calcium deposition. Additionally, Trelagliptin upregulated ALP, osteocalcin, OPN, and BMP2 and Runx2 in MC3T3-E1 cells. |